Literature DB >> 23509569

Integrating a brief pharmacist intervention into practice: Osteoporosis pharmacotherapy assessment.

Leah Phillips, Robert Ferguson, Katherine Diduck, Darcy Lamb, Derek Jorgenson.   

Abstract

Year:  2012        PMID： 23509569      PMCID： PMC3567584          DOI： 10.3821/145.5.cpj218

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  8 in total

1.  Inappropriate prescriptions for the aging population of the United States: an analysis of the National Ambulatory Medical Care Survey, 1997.

Authors:  Boji Huang; Kenneth A Bachmann; Xuming He; Randi Chen; Jennifer S McAllister; Tongtong Wang
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-03       Impact factor: 2.890

2.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors:  Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

3.  Factors affecting collaborative care between pharmacists and physicians.

Authors:  William R Doucette; Justin Nevins; Randal P McDonough
Journal:  Res Social Adm Pharm       Date:  2005-12

4.  The challenge of integrating community pharmacists into the primary health care team: a case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration.

Authors:  Fay Bradley; Rebecca Elvey; Darren M Ashcroft; Karen Hassell; Juliette Kendall; Bonnie Sibbald; Peter Noyce
Journal:  J Interprof Care       Date:  2008-08       Impact factor: 2.338

5.  Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.

Authors:  Peter J Zed; Riyad B Abu-Laban; Robert M Balen; Peter S Loewen; Corinne M Hohl; Jeffrey R Brubacher; Kerry Wilbur; Matthew O Wiens; Leslie J Samoy; Katie Lacaria; Roy A Purssell
Journal:  CMAJ       Date:  2008-06-03       Impact factor: 8.262

6.  What do community pharmacists think about undertaking screening and brief interventions with problem drinkers? Results of a qualitative study in New Zealand and England.

Authors:  Emma Horsfield; Janie Sheridan; Claire Anderson
Journal:  Int J Pharm Pract       Date:  2011-04-28

7.  Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk.

Authors:  R T Tsuyuki; J A Johnson; K K Teo; M L Ackman; R S Biggs; A Cave; W C Chang; V Dzavik; K B Farris; D Galvin; W Semchuk; S H Simpson; J G Taylor
Journal:  Ann Pharmacother       Date:  1999-09       Impact factor: 3.154

8.  Asthma friendly pharmacies: a model to improve communication and collaboration among pharmacists, patients, and healthcare providers.

Authors:  Tricia M Berry; Theresa R Prosser; Kristin Wilson; Mario Castro
Journal:  J Urban Health       Date:  2011-02       Impact factor: 3.671
  8 in total
  2 in total

1.  Guidelines for pharmacists integrating into primary care teams.

Authors:  Derek Jorgenson; Dan Dalton; Barbara Farrell; Ross T Tsuyuki; Lisa Dolovich
Journal:  Can Pharm J (Ott)       Date:  2013-11

2.  Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid.

Authors:  Wade Thompson; Barbara Farrell; Vivian Welch; Peter Tugwell; Lise M Bjerre
Journal:  Can Pharm J (Ott)       Date:  2016-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.